Shanghai JUNJIE Bio-Technolgy

Located in State Bio-Pharmaceutical Base of Zhangjiang Hi-Tech Park, Junjie is a professional plant-extraction and semi-synthesis factory. Company mainly produces and manages high-quality anti-tumor medicine APIs intermediates, including series of paclitaxel and camptothecin. Junjie owns a powerful team and these elites are from different backgrounds, such as extraction process, semi-synthetic chemical modification, research of preparation technology, marketing, international trade, project development and investment management. 80% of company staff has undergraduate degree or higher, the average age is under 32 years. Company has passed ISO9001 quality management system certification, and it’s a vigorous, dynamic and proactive enterprise. Junjie has owned a wide variety of products in short period, and made a major breakthrough on comprehensive utilization of taxus and synthesis and modification of taxol pharmaceutical ingredients. Meanwhile, the synthesis and development of the products of camptothecin series have been also successful, and it lays a solid foundation for the sustainable development of company. Leading technology, high quality and best credit are the bases of our sustainable development and long-term strategy. Currently, we are keen on establishing an integrated industry chain, exploiting related products and continuously launching new products. We approach to cooperate with all of our clients together to exploit Chinese herbal medicine market, to modernize Chinese Traditional Medicine.